| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...866294P |
| P356 | DOI | 10.1371/JOURNAL.PONE.0066294 |
| P932 | PMC publication ID | 3673910 |
| P698 | PubMed publication ID | 23755305 |
| P5875 | ResearchGate publication ID | 237098716 |
| P2093 | author name string | Yong-Xu Wang | |
| Chunxiao Mao | |||
| Dongning Pan | |||
| P2860 | cites work | Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I). | Q51952874 |
| The glucose-6-phosphatase catalytic subunit gene promoter contains both positive and negative glucocorticoid response elements | Q80411458 | ||
| Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas | Q82615010 | ||
| The histone demethylase Jhdm1a regulates hepatic gluconeogenesis | Q21144913 | ||
| LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer | Q24308737 | ||
| KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints | Q24312768 | ||
| Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis | Q24313608 | ||
| The role of HNF1alpha, HNF3gamma, and cyclic AMP in glucose-6-phosphatase gene activation | Q24336697 | ||
| Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 | Q24336747 | ||
| A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death | Q24644712 | ||
| High-resolution profiling of histone methylations in the human genome | Q27860906 | ||
| Coordinated histone modifications mediated by a CtBP co-repressor complex | Q28191656 | ||
| CoREST is an integral component of the CoREST- human histone deacetylase complex | Q28199886 | ||
| Factors that control the tissue-specific transcription of the gene for phosphoenolpyruvate carboxykinase-C | Q28252951 | ||
| Glycogen storage disease in adults | Q28257866 | ||
| An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation | Q28265681 | ||
| Opposing LSD1 complexes function in developmental gene activation and repression programmes | Q28295495 | ||
| Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy | Q28296663 | ||
| The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation | Q28304726 | ||
| Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer | Q28477572 | ||
| Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease | Q28592482 | ||
| Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice | Q29614547 | ||
| Quantitative contributions of gluconeogenesis to glucose production during fasting in type 2 diabetes mellitus | Q31922047 | ||
| trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1. | Q33279148 | ||
| What is a cAMP response unit? | Q33943495 | ||
| Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications | Q33997049 | ||
| Enhancer decommissioning by LSD1 during embryonic stem cell differentiation | Q34088491 | ||
| CREB and the CRTC co-activators: sensors for hormonal and metabolic signals | Q34166530 | ||
| Hepatocellular carcinoma in glycogen storage disease type Ia: a case series | Q34557393 | ||
| Characterization of the human liver fructose-1,6-bisphosphatase gene promoter | Q34646814 | ||
| Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study | Q35606593 | ||
| Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | Q35968941 | ||
| Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia | Q36515569 | ||
| Hormonal regulation of hepatic glucose production in health and disease | Q37896899 | ||
| LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells. | Q39538448 | ||
| Establishment and characterization of a novel method for evaluating gluconeogenesis using hepatic cell lines, H4IIE and HepG2. | Q39792281 | ||
| Insulin represses phosphoenolpyruvate carboxykinase gene transcription by causing the rapid disruption of an active transcription complex: a potential epigenetic effect | Q40210118 | ||
| Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature | Q41460619 | ||
| Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone | Q41654924 | ||
| Measurement of fractional whole-body gluconeogenesis in humans from blood samples using 2H nuclear magnetic resonance spectroscopy | Q44599785 | ||
| The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells | Q45375299 | ||
| NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism | Q46057176 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e66294 | |
| P577 | publication date | 2013-06-05 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Suppression of gluconeogenic gene expression by LSD1-mediated histone demethylation | |
| P478 | volume | 8 |
| Q43094404 | 3,5-Diamino-1,2,4-triazoles as a novel scaffold for potent, reversible LSD1 (KDM1A) inhibitors |
| Q47147249 | Cofactors As Metabolic Sensors Driving Cell Adaptation in Physiology and Disease |
| Q58755150 | FBP1 loss contributes to BET inhibitors resistance by undermining c-Myc expression in pancreatic ductal adenocarcinoma |
| Q92644570 | Fructose-1,6-bisphosphatase loss modulates STAT3-dependent expression of PD-L1 and cancer immunity |
| Q89176324 | Inhibition of the histone demethylase KDM4B leads to activation of KDM1A, attenuates bacterial-induced pro-inflammatory cytokine release, and reduces osteoclastogenesis |
| Q28084375 | Local chromatin microenvironment determines DNMT activity: from DNA methyltransferase to DNA demethylase or DNA dehydroxymethylase |
| Q51392646 | Loss of FBP1 facilitates aggressive features of hepatocellular carcinoma cells through the Warburg effect. |
| Q40796520 | Lysine-specific demethylase 1-mediated demethylation of histone H3 lysine 9 contributes to interleukin 1β-induced microsomal prostaglandin E synthase 1 expression in human osteoarthritic chondrocytes |
| Q41522109 | Lysine-specific demethylase 2 suppresses lipid influx and metabolism in hepatic cells |
| Q38662691 | Medicinal chemistry insights in the discovery of novel LSD1 inhibitors |
| Q92316777 | Metabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor Progression |
| Q92701392 | Metabolic and Epigenetic Action Mechanisms of Antidiabetic Medicinal Plants |
| Q57816641 | Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets |
| Q38929402 | Perspectives on the interactions between metabolism, redox, and epigenetics in plants |
| Q57072624 | Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer |
| Q33917658 | Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? |
| Q59137601 | Restoration of FBP1 suppressed Snail-induced epithelial to mesenchymal transition in hepatocellular carcinoma |
| Q52647812 | Targeting FBPase is an emerging novel approach for cancer therapy. |
| Q30399200 | The histone methyltransferase Suv39h2 contributes to nonalcoholic steatohepatitis in mice. |
| Q47637379 | Transcription factor 19 interacts with histone 3 lysine 4 trimethylation and controls gluconeogenesis via the nucleosome-remodeling-deacetylase complex |
| Q61810256 | Unraveling the Regulation of Hepatic Gluconeogenesis |
Search more.